This Article Free Full Text (Free OnlineFirst PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Scopus Google Scholar Articles by Bomback, A. S. Articles by Klemmer, P. J. PubMed PubMed Citation Articles by Bomback, A. S. Articles by Klemmer, P. J. Social Bookmarking                         What's this?

Disordered aldosterone-volume relationship in end-stage kidney disease

¹ Columbia University, College of Physicians and Surgeons, Department of Medicine, Division of Nephrology, New York, NY, USA
² UNC Kidney Center, Department of Medicine, Division of Nephrology and Hypertension, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

^* To whom correspondence should be addressed. E-mail: asb68{at}columbia.edu.

	Abstract

Introduction. Sodium loading, and subsequent volume expansion, suppresses aldosterone levels in individuals with normal renal function. We hypothesised that loss of renal function impairs this volume-aldosterone relationship.

Materials and methods. With multifrequency bioimpedance spectroscopy, we measured total body water (TBW), extracellular volume (ECV), and intracellular volume in five haemodialysis patients at varied states of hydration and in five healthy volunteers during low-, normal-, and high-salt diets. Serum aldosterone, potassium, and C-reactive protein were measured simultaneously. Scatterplots and general estimating equations were used to examine the relationship among these variables.

Results. In healthy volunteers with salt loading, and in haemodialysis subjects with increased inter-dialytic weight gain, expansion of ECV led to reciprocal declines in serum aldosterone concentrations. The relationship was more profound in healthy volunteers (p<0.001) than in haemodialysis subjects (p=0.1). Notably, haemodialysis subjects posted consistently higher levels of ECV (median 49.6% TBW, IQR 43.9–51.8% compared to 41.1%, 39.9–42.8% in volunteers) and serum aldosterone (median 26.7 ng/dl, IQR 19.8–29.6 compared to 12.4 ng/dl, 8.8–16.0 in volunteers). Serum potassium did not appear to influence aldosterone concentration (p=0.9).

Conclusions. The shift of the volumealdosterone curve in haemodialysis subjects suggests that end-stage kidney disease is a state of high volume and inappropriately high aldosterone. These data have important clinical implications, as dialysis patients may benefit from both volume reduction and mineralocorticoid receptor blockade.

First published on October 28, 2009
Journal of Renin-Angiotensin-Aldosterone System 2009, doi:10.1177/1470320309352353


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?